You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Gastric precancerous lesion follow up based on pathological evidence
  1. M Cassaro1,
  2. G Pennelli1,
  3. M Rugge1,
  4. F Farinati2,
  5. G Zaninotto3
  1. 1Department of Surgical and Oncological Sciences, University of Padova, Via A. Gabelli 61, I-35121 Padova, Italy; massimo.rugge@unipd.it
  2. 2Department of Surgical and Gastroenterological Sciences, University of Padova
  3. 3Department of Surgical and Medical Sciences, University of Padova

    https://doi.org/10.1136/jcp.2004.018069

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      We read with interest the article by Dinis-Ribeiro et al addressing the follow up of “atrophic chronic gastritis and intestinal metaplasia (IM)”.1 The authors conclude that: (1) “in patients with atrophic chronic gastritis or with type I IM, a three yearly follow up could be suitable”; and (2) “patients with type III IM may benefit from 6–12 monthly (follow up?)”.

      How precancerous lesions are histologically assessed and followed up are fields of our interest and we would raise some methodological concerns about the published study.

      In assessing atrophy, it would be advisable to adopt the classification(s) proposed by the current international literature. The original …

      View Full Text